Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement, Branded Medicines for London and South of England

NHS England

This public procurement record has 2 releases in its history.

Award

17 Sep 2021 at 16:11

Award Notice
Award

17 Sep 2021 at 16:08

Award Notice
Summary of the contracting process

The procurement process involves the NHS England as the contracting authority seeking to establish a framework agreement for branded medicines in London and the South of England. The title of the tender is "NHS Framework Agreement, Branded Medicines for London and South of England," classified under the pharmaceutical products category (CPV code 33600000). The contract period runs from 1 September 2021 to 31 August 2023, with options for extensions. The procurement method is an open procedure, with a total contract value estimated at £441,994,547 and key dates indicating that the tender period ended on 4 June 2021.

This tender presents significant opportunities for businesses engaged in the pharmaceutical sector, particularly small to medium-sized enterprises (SMEs) well-positioned to compete for contracts in supplying branded medicines. Given the extensive scope of the framework covering various regions, including the East Midlands, London, and the North West, suppliers that can demonstrate experience in pharmaceutical distribution and compliance with NHS regulations will be well-suited for participation. The framework can help SMEs expand their market reach through collaborative engagements within a highly regulated and lucrative healthcare environment.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement, Branded Medicines for London and South of England

Notice Description

NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER (FTS) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 6 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/80bd00f1-7cd9-4d19-804e-84505b1f615d
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£441,994,547 £100M-£1B
Lots Value
Not specified
Awards Value
£558,521,926 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
17 Sep 20214 years ago
Submission Deadline
4 Jun 2021Expired
Future Notice Date
Not specified
Award Date
19 Aug 20215 years ago
Contract Period
1 Sep 2021 - 31 Aug 2023 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
42
Supplier Names

Dr.Reddy's Laboratories (UK) Limited

Accord-UK Ltd

Techdow Pharma England Ltd

UL Global Pharma

Biogen Idec Limited

Amgen Ltd

THORNTON & ROSS LIMITED

Merck Sharpe & Dohme (UK) Limited

Bayer Plc

Zentiva Pharma UK Ltd

Napp Pharmaceuticals Ltd

Novo Nordisk

Daiichi Sankyo UK Ltd

Gedeon Richter UK Ltd

Teva UK Limited

Pfizer Ltd

Roche Products Ltd

Janssen-Cilag Ltd

Mylan

Allergan

Organon Pharmaceuticals UK Ltd

Sandoz Ltd

Celltrion Healthcare

Swedish Orphan Biovitrum Ltd

Merck Serono Limited

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

Eli Lilly & Company Ltd

Vifor Pharma UK Ltd

Merz

Takeda UK Limited

ASTRAZENECA UK LIMITED

Ferring Pharmaceuticals Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

Pharmacosmos UK Ltd

Tetris Pharma Lts

Ipsen

Profile Pharma Ltd

CST Pharma Limited

Gilead Sciences Ltd

Morningside Pharmaeuticals

Chugai

UCB

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...